#bristolmyerssquibb — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #bristolmyerssquibb, aggregated by home.social.
-
Medication cost prevents cancer patient from accessing treatment
GOSNELL, Ark. (KAIT) – Jen Holifield has multiple myeloma, an incurable blood cancer. Her doctor prescribed Lenalidomide —…
#NewsBeep #News #Medication #BristolMyersSquibb #CA #Canada #cancer #celgene #gosnell #Health #medications #MultipleMyeloma #PBM #pharmacy #remsdrugdistribution #REVLIMID
https://www.newsbeep.com/ca/525564/ -
https://www.europesays.com/uk/814683/ Medication cost prevents cancer patient from accessing treatment #BristolMyersSquibb #Cancer #celgene #gosnell #Health #Medication #medications #MultipleMyeloma #pbm #pharmacy #RemsDrugDistribution #REVLIMID #UK #UnitedKingdom
-
https://www.europesays.com/ie/333384/ Nektar, continuing comeback, says eczema drug’s effects hold up in follow-up study #BristolMyersSquibb #CompetitiveAdvantage #DrugTargets #Eczema #Éire #FoodAndDrugAdministration #Health #IE #Ireland #MaintenanceDose #Medication #NektarTherapeutics
-
Nektar, continuing comeback, says eczema drug’s effects hold up in follow-up study
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
#NewsBeep #News #Medication #BristolMyersSquibb #CA #Canada #competitiveadvantage #drugtargets #Eczema #foodanddrugadministration #Health #maintenancedose #NektarTherapeutics
https://www.newsbeep.com/ca/469961/ -
https://www.europesays.com/uk/759219/ Nektar, continuing comeback, says eczema drug’s effects hold up in follow-up study #BristolMyersSquibb #CompetitiveAdvantage #DrugTargets #eczema #FoodAndDrugAdministration #Health #MaintenanceDose #Medication #NektarTherapeutics #UK #UnitedKingdom
-
https://www.europesays.com/ie/239936/ These 2 Healthcare Stocks Just Declared Dividend Raises #BristolMyersSquibb #Éire #GrowthPortfolio #Health #HealthCare #Healthcare #IE #Ireland #PharmaceuticalCompany #Zoetis
-
Trump empuja a las farmacéuticas a subir los precios de los medicamentos en Europa para bajarlos en EE UU
-
https://www.fogolf.com/1022613/pfizer-ceo-attending-25-million-fundraiser-at-trumps-golf-club-sources-say/ Pfizer CEO attending $25 million fundraiser at Trump’s golf club, sources say #AlbertBourla #BristolMyersSquibb #Donald #DonaldTrump #DonaldTrumpGolf #DonaldTrumpGolfing #DrugPrices #Pfizer #PharmaceuticalCompanies #PresidentTrump #trump #TrumpGolf #TrumpGolfing #WhiteHouse
-
Gilead’s Trodelvy stumbles in late-stage trials but remains prized cancer asset—BMS axes Eisai ADC pact 3 years after paying $650M for would-be Elahere rival —Supreme Court’s Chevron Doctrine ruling could limit FDA’s regulatory authority—http://bit.ly/w28kSd #gileadsciences #cancer #antibodydrugconjufate #eisai #bristolmyerssquibb #supremecourt #fda #chevrondoctrine #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
5 FDA decisions to watch in the second half of 2024—Lilly sees path for Zepbound’s label expansion with phase III sleep apnea win —BMS gets FDA approval for Krazati in colorectal cancer—http://bit.ly/w28kSd #fda #elililly #sleepapnea #bristolmyerssquibb #colorectalcancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
ASCO: With Opdivo-Yervoy combo, Bristol Myers calls Roche and AstraZeneca's bets in first-line liver cancer—FDA panel to review psychedelic drug MDMA for first time — Abbott’s OTC glucose monitor ‘will grow the market’—http://bit.ly/w28kSd #asco2024 #oncology #cancer #bristolmyerssquibb #livercancer #mdma #fda #abbottlabs #cgm #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
J&J to buy Proteologix and its dual-targeting antibody drugs for $850M—Biogen walks away from Ionis-partnered ALS, Angelman prospects after peek at clinical data —FDA approves expanded use of Bristol Myers' cancer cell therapy --http://bit.ly/w28kSd #jnj #biogen #als #celltherapy #fda #bristolmyerssquibb #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
J&J to buy Proteologix and its dual-targeting antibody drugs for $850M—Biogen walks away from Ionis-partnered ALS, Angelman prospects after peek at clinical data —FDA approves expanded use of Bristol Myers' cancer cell therapy --http://bit.ly/w28kSd #jnj #biogen #als #celltherapy #fda #bristolmyerssquibb #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
J&J to buy Proteologix and its dual-targeting antibody drugs for $850M—Biogen walks away from Ionis-partnered ALS, Angelman prospects after peek at clinical data —FDA approves expanded use of Bristol Myers' cancer cell therapy --http://bit.ly/w28kSd #jnj #biogen #als #celltherapy #fda #bristolmyerssquibb #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
J&J to buy Proteologix and its dual-targeting antibody drugs for $850M—Biogen walks away from Ionis-partnered ALS, Angelman prospects after peek at clinical data —FDA approves expanded use of Bristol Myers' cancer cell therapy --http://bit.ly/w28kSd #jnj #biogen #als #celltherapy #fda #bristolmyerssquibb #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
J&J scoops up cardio medtech Shockwave Medical for $13.1B—FDA allows expanded use of Bristol Myers' cell therapy for blood cancer—Boehringer to lay off salespeople as Humira biosimilar sales lag--http://bit.ly/w28kSd #jnj #shockwavemedical #fda #mergersandacquisitions #celltherapy #bloodcancer #bristolmyerssquibb #humira #boehringer #layoffs #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
J&J scoops up cardio medtech Shockwave Medical for $13.1B—FDA allows expanded use of Bristol Myers' cell therapy for blood cancer—Boehringer to lay off salespeople as Humira biosimilar sales lag--http://bit.ly/w28kSd #jnj #shockwavemedical #fda #mergersandacquisitions #celltherapy #bloodcancer #bristolmyerssquibb #humira #boehringer #layoffs #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
J&J scoops up cardio medtech Shockwave Medical for $13.1B—FDA allows expanded use of Bristol Myers' cell therapy for blood cancer—Boehringer to lay off salespeople as Humira biosimilar sales lag--http://bit.ly/w28kSd #jnj #shockwavemedical #fda #mergersandacquisitions #celltherapy #bloodcancer #bristolmyerssquibb #humira #boehringer #layoffs #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Lilly makes weight-loss drug Zepbound available through Amazon pharmacy—Merck to start trials investigating single dosing regiments of HPV vaccine—FDA staff raises concerns over data from J&J, Bristol's CAR-T therapies--http://bit.ly/w28kSd #amazon #elililly #zebound #merck #clinicaltrials #hpv #vaccines #gardasil #jnj #bristolmyerssquibb #cart #fda #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Lilly makes weight-loss drug Zepbound available through Amazon pharmacy—Merck to start trials investigating single dosing regiments of HPV vaccine—FDA staff raises concerns over data from J&J, Bristol's CAR-T therapies--http://bit.ly/w28kSd #amazon #elililly #zebound #merck #clinicaltrials #hpv #vaccines #gardasil #jnj #bristolmyerssquibb #cart #fda #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Lilly makes weight-loss drug Zepbound available through Amazon pharmacy—Merck to start trials investigating single dosing regiments of HPV vaccine—FDA staff raises concerns over data from J&J, Bristol's CAR-T therapies--http://bit.ly/w28kSd #amazon #elililly #zebound #merck #clinicaltrials #hpv #vaccines #gardasil #jnj #bristolmyerssquibb #cart #fda #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Federal #court in #Texas dismissed #lawsuit brought by heavy-hitting #pharmaceutical trade group, #PhRMA, which argued forcing #drug makers to negotiate #Medicare #drugprices is #unconstitutional. The big pharmaceutical companies suing government directly over negotiations include J&J, #BristolMyersSquibb, #NovoNordisk, #Merck, and #AstraZeneca. District Judge David Ezra found they first need to bring claims through an administrative review process under the #MedicareAct https://arstechnica.com/science/2024/02/judge-tosses-big-pharma-suit-claiming-drug-price-negotiation-is-unconstitutional/
-
Viking Therapeutics' weight-loss drug trial success spurs share surge—BioMarin hit with DOJ subpoena on sponsored testing for rare diseases—Bristol Myers CEO says India to have largest R&D presence outside US by 2025--http://bit.ly/w28kSd #weightloss #clinicaltrials #biomarin #doj #raredisease #india #bristolmyerssquibb #researchanddevelopment #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Viking Therapeutics' weight-loss drug trial success spurs share surge—BioMarin hit with DOJ subpoena on sponsored testing for rare diseases—Bristol Myers CEO says India to have largest R&D presence outside US by 2025--http://bit.ly/w28kSd #weightloss #clinicaltrials #biomarin #doj #raredisease #india #bristolmyerssquibb #researchanddevelopment #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
BMS more likely to bet on bolt-ons after recent buying spree—As Humira plummets, AbbVie dials up Rinvoq and Skyrizi estimates to a combined $27B — Brain drug developer Alto Neuroscience prices $129M IPO--http://bit.ly/w28kSd #bristolmyerssquibb #mergersandacquisitions #abbvie #earnings #humira #ipos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
BMS more likely to bet on bolt-ons after recent buying spree—As Humira plummets, AbbVie dials up Rinvoq and Skyrizi estimates to a combined $27B — Brain drug developer Alto Neuroscience prices $129M IPO--http://bit.ly/w28kSd #bristolmyerssquibb #mergersandacquisitions #abbvie #earnings #humira #ipos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
BMS more likely to bet on bolt-ons after recent buying spree—As Humira plummets, AbbVie dials up Rinvoq and Skyrizi estimates to a combined $27B — Brain drug developer Alto Neuroscience prices $129M IPO--http://bit.ly/w28kSd #bristolmyerssquibb #mergersandacquisitions #abbvie #earnings #humira #ipos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Novo Nordisk bolsters obesity pipeline with potential $500M Embark Biotech buy -- AmerisourceBergen no more: Company changes name to Cencora -- Bristol Myers gets key FDA approval for bone marrow disease drug -- See more on our front page news http://bit.ly/w28kSd #novonordisk #mergersandacquisitions #obesity #amerisourcebergen #cencora #bristolmyerssquibb #fda #drugapprovals #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
7 life science IPOs in 2023 — 7 companies are rolling out Humira biosimilars -- Bristol Myers' Opdivo stages comeback in bladder cancer, teeing up 2 'Merck' showdowns -- See more on our front page news http://bit.ly/w28kSd #ipos #lifesciences #biosimilars #abbvie #humira #opdivo #bladdercancer #bristolmyerssquibb #merck #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
7 life science IPOs in 2023 — 7 companies are rolling out Humira biosimilars -- Bristol Myers' Opdivo stages comeback in bladder cancer, teeing up 2 'Merck' showdowns -- See more on our front page news http://bit.ly/w28kSd #ipos #lifesciences #biosimilars #abbvie #humira #opdivo #bladdercancer #bristolmyerssquibb #merck #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
ASCO 2023 news drops ahead of June meeting: Merck, BMS, Regeneron, and more — Noom to offer prescriptions for weight-loss drugs --ASCO puts spotlight on advancing antibody-drug conjugate pipeline -- See more on our front page news http://bit.ly/w28kSd #asco2023 #asco23 #merck #regeneron #bristolmyerssquibb #antibodydrugconjugate #noom #wegovy #weightloss #ozempic #novonordisk #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
ASCO 2023 news drops ahead of June meeting: Merck, BMS, Regeneron, and more — Noom to offer prescriptions for weight-loss drugs --ASCO puts spotlight on advancing antibody-drug conjugate pipeline -- See more on our front page news http://bit.ly/w28kSd #asco2023 #asco23 #merck #regeneron #bristolmyerssquibb #antibodydrugconjugate #noom #wegovy #weightloss #ozempic #novonordisk #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Biotech industry leaders share cautious optimism for 2023 amid downturn and layoffs - Inside Absci’s labs. (Absci Photo)
Sujal Patel has been here before.
He wea... - https://www.geekwire.com/2022/biotech-industry-leaders-share-cautious-optimism-for-2023-amid-downturn-and-layoffs/ #sonomabiotherapeutics #health/lifesciences #bristolmyerssquibb #williamcanestaro #lumenbioscience #phasegenomics #marccummings #brianfinrow #ivanliachko #sujalpatel #seagen
-
Someone plz find me a full list of #SLF¹ members & supporters. We know of these corps: #FedEx, #BristolMyersSquibb, #Facebook, #ATT, #UnitedAirlines, #Abbott, #3M, #Microsoft, #Deloitte, #Fidelity, #Chevron, #Intuit, #Xerox, #Pfizer, #Dow, #AllState, #Delta, & #CVS. That’s just the tip of the iceberg. 1. SLF: Senate Leadership Fund (aka Sellout Leeches Freeload fund; like #ALEC)